NCT01607086View on ClinicalTrials.gov

Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

July 11, 2008

Primary Completion Date

July 18, 2008

Study Completion Date

July 18, 2008

Conditions

Mental Disorders

Interventions

DRUG

Cherry lamotrigine ODT

25mg, taken orally on one study visit

DRUG

Cherry Placebo

Taken orally on one study visit

Trial Locations (1)

CB2 0QQ

GSK Investigational Site, Cambridge

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY